Japan

SCCR 21: General statement of Group B (covering broadcasting, AV protection and limitations and exceptions)

The following general statement was delivered by France, on behalf of Group B, on the first day (8 November 2010) of SCCR 21.

SCCR 21
Group B opening statement

I thank you M. Chair,

Group B is glad to welcome you back in Geneva for this 21st session of the Standing Committee on Copyright and Related Rights, which we hope will be a productive one.

Obama Administration role in the regulation of prices for medicine and medical devices in Japan

On July 6, 2009, a report of the the U.S.-Japan Regulatory Reform and Competition Policy Initiative was presented to President Obama and Prime Minister Aso of Japan. The report provides an insight into the degree that the U.S. government tries to influence prices for medicines and medical devices in foreign markets. Here, as in other foreign markets, the U.S. government seeks to raise prices, and to give industry an even greater role in setting the prices for their products.

Proposal of Group B for Recommendation to the PCT Assembly

Proposal of Group B for Recommendation to the Assembly

The Working Group of the PCT recognizes the willingness of all Contracting Parties to commit to developing the PCT in order to meet the needs of all applicants, Offices, third parties and the general public. Following its discussion of the roadmap presented in the document PCT/WG/2/3, the PCT Working Group makes the following recommendations to the Assembly.

Syndicate content